Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma.

Li-Bo ZhangRong-Rong PangQing-Hua QiaoZhi-Hua WangXin-Yi XiaChang-Jun WangXiao-Li Xu

Published in: Military Medical Research (2020)

When COVID-19 patients develop recurrent or refractory gastrointestinal symptoms and fail to respond to the available treatment, alternative therapy with convalescent plasma administration may be considered.

Keyphrases

sars cov
coronavirus disease
irritable bowel syndrome
sleep quality
respiratory syndrome coronavirus
depressive symptoms
mesenchymal stem cells
physical activity
clostridium difficile
replacement therapy
cell therapy
bone marrow